NeoGenomics, Inc. (NEO)

NeoGenomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	361.99	342.49	263.18	316.83	228.71	173.02
Short-Term Investments	25.82	72.72	174.81	198.56	67.55	-
Cash & Short-Term Investments	387.81	415.2	437.99	515.39	296.26	173.02
Cash Growth	-3.59%	-5.20%	-15.02%	73.97%	71.23%	1663.49%
Receivables	152.83	131.26	121.61	113.87	108.49	95.24
Inventory	24.46	24.16	24.28	23.4	29.53	14.41
Prepaid Expenses	18.24	17.99	15.24	12.35	11.55	6.33
Other Current Assets	6.91	8.2	6.18	16.5	2.91	1.75
Total Current Assets	590.24	596.81	605.29	681.51	448.73	290.74
Property, Plant & Equipment	174.48	183.78	198.61	211.66	131.66	90.68
Long-Term Investments	-	-	-	-	29.56	-
Goodwill	522.77	522.77	522.77	527.12	211.08	198.6
Other Intangible Assets	348.04	373.13	408.26	442.33	120.65	126.64
Long-Term Accounts Receivable	-	-	0.03	0.24	0.29	0.15
Long-Term Deferred Charges	0.03	0.05	0.72	0.88	0.97	0.8
Other Long-Term Assets	5.55	4.69	4.36	6.05	45.39	1.9
Total Assets	1,641	1,681	1,740	1,870	988.33	709.51
Accounts Payable	16.51	20.33	20.51	17.92	24.97	19.57
Accrued Expenses	75.16	68.23	55.21	53.1	36.38	28.91
Current Portion of Long-Term Debt	200.42	-	0.07	1.14	2.84	10.43
Current Portion of Leases	3.72	5.61	6.58	6.88	4.97	3.38
Current Unearned Revenue	0.59	2.13	7.56	5.19	4.03	1.61
Other Current Liabilities	-	-	-	3	-	-
Total Current Liabilities	296.41	96.3	89.93	87.23	73.18	63.9
Long-Term Debt	339.96	538.2	535.32	532.48	169.09	97.03
Long-Term Leases	62.17	67.87	68.95	72.29	42.3	24.03
Long-Term Unearned Revenue	0.4	-	0.02	0.92	0.71	1.17
Long-Term Deferred Tax Liabilities	22.77	24.29	34.75	55.48	5.42	15.57
Other Long-Term Liabilities	11.2	13.03	13.04	13.11	3.34	0.4
Total Liabilities	732.9	739.69	742.01	761.5	294.04	202.1
Common Stock	0.13	0.13	0.13	0.12	0.11	0.11
Additional Paid-In Capital	1,219	1,190	1,161	1,124	701.36	520.28
Retained Earnings	-310.46	-247.06	-159.09	-14.84	-7.19	-11.36
Comprehensive Income & Other	-0.64	-1.67	-3.9	-0.64	0.01	-1.62
Total Common Equity	908.21	941.54	998.02	1,108	694.29	507.41
Shareholders' Equity	908.21	941.54	998.02	1,108	694.29	507.41
Total Liabilities & Equity	1,641	1,681	1,740	1,870	988.33	709.51
Total Debt	606.27	611.68	610.93	612.79	219.19	134.88
Net Cash (Debt)	-218.46	-196.48	-172.94	-97.4	77.07	38.14
Net Cash Growth	-	-	-	-	102.06%	-
Net Cash Per Share	-1.73	-1.57	-1.39	-0.81	0.69	0.37
Filing Date Shares Outstanding	128.36	127.61	127.46	124.03	116.94	104.83
Total Common Shares Outstanding	128.06	127.37	126.91	124.11	112.08	104.78
Working Capital	293.84	500.51	515.36	594.28	375.55	226.83
Book Value Per Share	7.09	7.39	7.86	8.93	6.19	4.84
Tangible Book Value	37.4	45.64	67	138.84	362.56	182.17
Tangible Book Value Per Share	0.29	0.36	0.53	1.12	3.23	1.74
Land	-	-	-	-	3.17	3.17
Buildings	-	-	-	-	7.4	7.4
Machinery	-	142.03	136.88	127.95	103.5	70.77
Construction In Progress	-	3.61	8.98	12.4	6.29	7.17
Leasehold Improvements	-	49.23	44.42	43.25	27.69	23.68

Source: S&P Capital IQ. Standard template. Financial Sources.